H. Hsu

发表

The adaptor protein SH2B1β reduces hydrogen peroxide-induced cell death in PC12 cells and hippocampal neurons

Linyi Chen, Wan-Chen Lu, Chien-Jen Chen, 2010, Journal of molecular signaling.

Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression

P. Hwang, H. Hsu, Hong-Yu Tseng, 2020, Cancers.

Defining interactions between DNA-PK and ligase IV/XRCC4.

David J. Chen, H. Hsu, S. Yannone, 2002, DNA repair.

Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression

H. Hsu, Hong-Yu Tseng, L. Chen, 2017, Oncogenesis.

Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice

P. Hwang, H. Hsu, A. A. Al Haq, 2022, Journal of Biomedical Science.

The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells

R. Gartenhaus, H. Hsu, Bo Shi, 2005, Oncogene.

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

H. Hsu, Hong-Yu Tseng, Yen-An Chen, 2019, Molecular Cancer.

Isolation of Ku70-binding proteins (KUBs).

S. Yeh, D. Boothman, D. J. Chen, 1999, Nucleic acids research.

Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification.

H. Hsu, N. Yeh, Hsueh-Hsuan Lin, 2007, Journal of biomedical science.

Ku is associated with the telomere in mammals.

E. Blackburn, D. J. Chen, H. Hsu, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Ku acts in a unique way at the mammalian telomere to prevent end joining.

M. Hande, J. Campisi, D. J. Chen, 2000, Genes & development.

Dynamic changes of NuMA during the cell cycle and possible appearance of a truncated form of NuMA during apoptosis.

H. Hsu, N. Yeh, 1996, Journal of cell science.

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity

Linyi Chen, Hsin-Ling Hsu, Linyi Chen, 2012, Oncotarget.

The antagonism between MCT-1 and p53 affects the tumorigenic outcomes

Linyi Chen, H. Hsu, Ravi Kasiappan, 2010, Molecular Cancer.

Loss of p53 and MCT-1 Overexpression Synergistically Promote Chromosome Instability and Tumorigenicity

C. Shu, H. Hsu, Shiu-Feng Huang, 2009, Molecular Cancer Research.

Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies.

L. Gordon, A. Evens, R. Gartenhaus, 2003, Blood.

The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities

T. Ouchi, H. Hsu, Pei-Hsuan Wu, 2012, Cell cycle.

MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage.

C. Shu, R. Gartenhaus, H. Hsu, 2007, DNA repair.

Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression

P. Hwang, H. Hsu, Hong-Yu Tseng, 2017, Scientific Reports.

Interplay between Cell Migration and Neurite Outgrowth Determines SH2B1β-Enhanced Neurite Regeneration of Differentiated PC12 Cells

Linyi Chen, H. Hsu, Yu-Jung Chang, 2012, PloS one.

Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress

H. Hsu, Chien-Chia Wang, Hong-Yu Tseng, 2022, Cell death & disease.

Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression

P. Hwang, H. Hsu, Hong-Yu Tseng, 2017, Scientific Reports.

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

H. Hsu, Yen-An Chen, Li-Mei Chen, 2019, Molecular Cancer.

MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation

I. Chang, M. Wu, H. Hsu, 2014, Oncogene.

Sequence-specific targeting of Caenorhabditis elegans C-Ala to the D-loop of tRNAAla

Sun-Chong Wang, H. Hsu, Shao-Win Wang, 2023, The Journal of biological chemistry.

Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer

H. Hsu, Jou-Ho Shih, Yen-An Chen, 2024, Theranostics.